A Study of a Vaccine for Pneumonia in Adults and Toddlers in Kenya

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This study aimed to determine whether PATH-wSP, a vaccine against a germ that causes pneumonia, is safe and induces immune responses in adults and toddlers. The study vaccine was compared to placebo. First adults received 2 injections of a lower dose of the vaccine or placebo, 28 days apart. Since the lower dose was considered safe, a higher dose was tested. Once the safety was established in adults the lower and higher dose was tested in toddlers, starting with the lower dose and then the higher dose.
Epistemonikos ID: f2f4df6bd0a624eb3718c63d01ea35231e53d0f5
First added on: May 12, 2024